Efficacy and safety comparing prasugrel/ticagrelor and clopidogrel in Hong Kong post‐acute coronary syndrome patients–A 10‐year cohort study

BACKGROUND: Clinical evidence of prasugrel/ticagrelor in dual antiplatelet therapy (DAPT) in Asian acute coronary syndrome (ACS) population remains inconclusive. We aimed to compare the clinical efficacy and safety of prasugrel/ticagrelor compared to clopidogrel as part of DAPT in Hong Kong ACS popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Amy S. M., Yan, Bryan P. Y., Lee, Vivian W. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364718/
https://www.ncbi.nlm.nih.gov/pubmed/34041774
http://dx.doi.org/10.1002/clc.23653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364718/
https://www.ncbi.nlm.nih.gov/pubmed/34041774
http://dx.doi.org/10.1002/clc.23653

Ejemplares similares